Onion bulb extract can both reverse and prevent colitis in mice via inhibition of pro-inflammatory signaling molecules and neutrophil activity

• Published in: PloS one 2020-10, Vol.15 (10), p.e0233938-e0233938
• Main Authors: Khajah, Maitham A, EL-Hashim, Ahmed Z, Orabi, Khaled Y, Hawai, Sanaa, Sary, Hanan G, Body-Malapel, Mathilde
• Format: Article
• Language: English
• Subjects: Anti-inflammatory agents; Apoptosis; Biology and Life Sciences; Care and treatment; Cell survival; Cellular signal transduction; Colitis; Colon; Coronary vessels; Dextran; Dextran sulfate; Dextrans; Disease; Drinking water; Health aspects; Health sciences; Hypertension; Immune system; Immunofluorescence; Inflammation; Inflammatory bowel disease; Kinases; Leukocytes (neutrophilic); Medical treatment; Medicinal plants; Medicine and Health Sciences; Neutrophils; Obesity; Onions; Pharmacology; Pharmacy; Physical Sciences; Physiological aspects; Prevention; Superoxide; Tumor necrosis factor-TNF; Western blotting
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0233938

Background Onion is one of the most commonly used plants in the traditional medicine for the treatment of various diseases. We recently demonstrated the anti-inflammatory properties of onion bulb extract (OBE) in reducing colitis severity in mice when administered at the same time of colitis induction. However, whether onion can reverse established colitis or even prevent its development has not been investigated. Hypothesis To test 1. whether OBE can reduce colitis severity when given either before (preventative approach) or after (treatment approach) colitis induction and if so, 2. what are the mechanisms by which onion can achieve these effects. Methods Colitis was induced by dextran sulfate sodium (DSS) administration using treatment and preventative approaches. The severity of the inflammation was determined by the gross and histological assessments. The colonic level/activity of pro-inflammatory molecules and immune cell markers was assessed by immunofluorescence and western blotting analysis. In vitro neutrophil superoxide release and survival was assessed by chemilumenecense and Annexin-V/7AAD assays respectively. Results OBE treatment significantly reduced colitis severity in both approaches, the colonic expression/activity profile of pro-inflammatory molecules, inhibited WKYMVm-induced superoxide release, and increased spontaneous apoptosis of neutrophils in vitro. Conclusions OBE can be used as an effective option in the prevention and/or the treatment of established colitis.